Cardiometabolic Diseases Market Growth Accelerates: Strategic Forecast Predicts $137.81 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cardiometabolic Diseases Industry Market Size Be by 2025?
There has been a consistent expansion in the size of the cardiometabolic diseases market in the past few years. It's projected to escalate from $111.64 billion in 2024 to $115.7 billion in 2025, marking a compound annual growth rate (CAGR) of 3.6%. The upward trajectory in the previous period is largely due to factors such as sedentary living conditions, the trend of urbanization and lifestyle changes, industrialization coupled with the consumption of processed foods, genetic predispositions, and environmental elements.

What's the Long-Term Growth Forecast for the Cardiometabolic Diseases Market Size Through 2029?
The market size for cardiometabolic diseases is projected to witness a steady rise in the coming years, reaching $137.81 billion in 2029 with a compound annual growth rate (CAGR) of 4.5%. This growth during the prediction period can be associated with factors such as the obesity pandemic, an ageing populace, enhanced healthcare infrastructure, advancements in genomic and precision medicine, and issues related to chronic stress and mental health. Prominent trends for the forecast period encompass health education and awareness, corporate health schemes, community healthcare programs, a focus on preventive healthcare, and integrated care orientations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

What Are the Key Growth Drivers Fueling the Cardiometabolic Diseases Market Expansion?
The cardiometabolic disease market is predicted to advance due to the high prevalence of obesity. Defined by an excessive buildup of body fat resulting in increased body weight, obesity significantly contributes to the incidence of cardiovascular threats like dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. As per the World Health Organization (WHO), a global intergovernmental entity based in Switzerland, in March 2022, obesity affects over a billion people worldwide every year. This includes 340 million teenagers, 650 million adults, and 39 million children. Looking ahead, the WHO forecasts that 167 million adults and children will experience health decrease by 2025 due to overweight or obesity-related issues. Consequently, the rampant obesity rates are fueling the growth of the cardiometabolic diseases market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11929&type=smp

What Are the Key Trends Driving Cardiometabolic Diseases Market Growth?
Embracing novel technologies is a critical tendency growing in popularity in the cardiometabolic diseases market. Enterprises concentrating on the cardiometabolic diseases landscape are striving to incorporate innovative techniques to uphold their market position. As an example, Eko Health Inc., a creator of digital health tech for heart and lung disease detection based in the US, introduced the Sensora cardiac disease detection platform in February 2023. This system includes artificial intelligence (AI) proficient at detecting structural murmurs, which are indicative of valvular heart disease (VHD), and a care pathway analytics software that offers metrics and downstream insight into the patient's encounter with the healthcare system. This digital stethoscope has the capability to capture and evaluate electrical impulses and heartbeats.

How Is the Cardiometabolic Diseases Market Segmented?
The cardiometabolic diseases market covered in this report is segmented -

1) By Type: Chronic Or Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity
2) By Treatment: ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments
3) By Dosage: Tablet, Injection
4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
5) By End-Users: Clinic, Hospital, Other End-Users

Subsegments:
1) By Chronic Or Congestive Heart Failure: Systolic Heart Failure, Diastolic Heart Failure
2) By Hypertension: Primary Hypertension, Secondary Hypertension
3) By Type 2 Diabetes: Insulin Resistance, Impaired Glucose Tolerance
4) By Obesity: Class I Obesity (BMI 30-34.9), Class II Obesity (BMI 35-39.9), Class III Obesity (BMI 40 And above)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11929&type=smp

Which Companies Are Leading the Charge in Cardiometabolic Diseases Market Innovation?
Major companies operating in the cardiometabolic diseases market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Kowa Company Ltd., Thermo Fisher Scientific, Abbott Laboratories, Takeda Pharmaceutical Company, Eli Lilly and Company, Novo Nordisk A/S, Siemens Healthineers, Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Stryker Corporation, AstraZeneca Plc, Viatris Inc., Biocrates Life Sciences AG, Boston Scientific, Astellas Pharma Inc., Terumo Corporation, Agilent Technologies, Edwards Lifesciences, Bruker Corporation, Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Cardax Inc.

Which Regions Are Leading the Global Cardiometabolic Diseases Market in Revenue?
North America was the largest region in the cardiometabolic diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiometabolic diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11929

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.